Humber River Hospital
Toronto, Ontario, M3N 1N1, Canada
NCT Number: NCT02321215
The purpose of this study is to determine if it is effective and feasible to provide a chronic obstructive pulmonary disease (COPD) education program to patients admitted with an acute exacerbation of COPD.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Toronto, Ontario, M3N 1N1, Canada
Following an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) evidence strongly suggests that all patients should be discharged with an action plan, consisting of identified patient responsibilities for their ongoing care and advice on recognizing and seeking help in the event of future acute exacerbations. Despite these recommendations, structured chronic obstructive pulmonary disease (COPD) specific education is rarely offered within acute hospital settings and, in addition, research in this area is limited. This study aims to determine the effectiveness and feasibility of an introductory education program delivered during and shortly after an AECOPD hospitalization.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This intervention will consist of two one-on-one education sessions, each lasting 30 minutes.
Other names: COPD Education Program
Time frame: This primary outcome measure will be collected prior to randomization and approximately four weeks after admission
Bristol COPD Knowledge Questionnaire (BCKQ)
Time frame: This primary outcome measure will be collected prior to randomization and approximately four weeks after admission
Lung Information Needs Questionnaire (LINQ)
Time frame: This outcome variable will be noted within 1-2 days of hospital admission with an AECOPD (when determining patient eligibility, before randomization).
Time frame: This outcome variable will be noted within 1-2 days of hospitalization, while the patient is being recruited (before randomization).
Questions: (1) Is it easy to locate the patient in their room? (Yes/No) (2) How many times did the RA try to find the patient in the room before successfully finding them there? (#) (3) Does the patient have enough time to meet with the RA? (Yes/No)
Time frame: This outcome measure will be noted after each education session. The education sessions will take place between 3-15 days after hospital admission for an AECOPD. Two education sessions will be delivered to every patient enrolled in the intervention arm.
Questions: (1) Is the participant able to complete the half-hour session? (Yes/No) (2) How many times was the education session interrupted for any reason? (#)
Time frame: This outcome variable will be noted between days 20-30 following admission to hospital (approximately four weeks after hospital admission).
Proportion of subjects that complete the follow up stage (questionnaire responses)
West Park Healthcare Centre
Other
Effectiveness and Feasibility of Delivering an Introductory Education Program to Patients Admitted to Hospital With an Acute Exacerbation of COPD - a Pilot Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03458364
Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation
Yantai, Shandong, China
View Trial DetailsNCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06614959
Bronchial Diseases, Bronchitis
Montreal, Quebec, Canada
View Trial DetailsNCT06040086
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD)
Birmingham, Alabama, United States
View Trial Details